This study examines the mechanism of relaxation of isolated endothelium-removed bovine coronary arteries (BCAs) to the thiol oxidant diamide. BCAs precontracted with KCl or the thromboxane A 2 receptor agonist U46619 showed a concentration-dependent reversible relaxation on exposure to 10 mol/L to 1 mmol/L diamide. This relaxation was enhanced by an inhibitor of glutathione reductase, and it was not altered by severe hypoxia, the presence of inhibitors of soluble guanylate cyclase, K ϩ channels, tyrosine kinases, or probes that modulate levels of superoxide. The relaxation was almost eliminated when BCAs were precontracted with a phorbol ester that causes a contraction that is largely independent of extracellular Ca 2ϩ . The initial transient contraction elicited by 5-hydroxytryptamine in Ca 2ϩ -free solution was not altered by the presence of 1 mmol/L diamide; however, a subsequent tonic contraction on addition of CaCl 2 was inhibited by diamide. Diamide also inhibited contractions caused by the addition of CaCl 2 to Ca 2ϩ -free Krebs' buffer containing Bay K8644 (an L-type Ca 2ϩ channel opener) or KCl. Relaxation to diamide was attenuated by L-type Ca 2ϩ channel blockers (nifedipine and diltiazem). Thus, thiol oxidation elicited by diamide appears to activate a novel redox-regulated vasodilator mechanism that seems to inhibit extracellular Ca 2ϩ influx. (Arterioscler Thromb Vasc Biol. 2000;20:2359-2365.)
I ntracellular thiols are known to be a major cellular defense mechanism for oxidant stress, and changes in cellular redox status have been proposed to play a role in vascular tone responses. There is evidence that alterations in the thiol redox of key sites on regulatory proteins is a potential mechanism of controlling the function of these systems in a signaling-like manner. 1 The thiol oxidant diamide is known to promote the reversible oxidation of glutathione (GSH) and adjacent protein thiols (RSH) to their disulfide forms [GSSG and R(S-S)] and to promote the S-thiolation (eg, RSSG) of reactive protein thiols. 2 Diamide was initially observed by Weir et al 3 to cause vasodilation in the precontracted pulmonary circulation. This observation evolved into studies showing that oxidants opened plasma membrane K ϩ channels in pulmonary arterial smooth muscle through a mechanism potentially mediated through thiol oxidation. 4 These studies also contributed to the development of a hypothesis for the involvement of thiol redox regulated K ϩ channels in the process in pulmonary hypoxic vasoconstriction. 4, 5 There is also substantial evidence that soluble guanylate cyclase (sGC) is an additional vasodilator mechanism that could be controlled by interactions between oxidants and thiol redox. 6 -8 The oxidation of GSH is also likely to increase the levels of intracellular peroxides and reactive hydroxyl radical-like species derived from peroxides in a manner that could enhance the magnitude of the signaling actions of these species. Multiple additional cellular control systems, such as tyrosine phosphorylation-initiated activation of the G protein p21 ras , phospholipases A 2 , C, and D, protein kinase C, and mitogen-activated protein kinases, 9 -11 key enzymes in energy metabolism, 12 and systems that control the storage and release of Ca 2ϩ 13,14 could be regulated by processes linked to oxidants and thiol redox. Thus, thiol redox could control multiple systems that are involved in the regulation of vascular force.
In the present study, we examined the mechanism through which diamide causes relaxation of isolated endotheliumremoved bovine coronary arteries (BCAs). Endothelium was removed to avoid the complicating effects of redox changes on endothelial mediator release. The present study began with investigating the role of stimulation of increases in sGC activity, K ϩ channel opening, and reactive O 2 species in the mechanism of relaxation of BCAs elicited by diamide because of the existing evidence 1 that these processes could potentially control vascular contractile function through a regulatory mechanism normally modulated by changes in thiol redox. However, additional regulatory mechanisms po-tentially influenced by thiol redox had to be explored when the initial studies did not detect a role for these mechanisms in the relaxant actions of diamide. The subsequent detection of evidence of a role of inhibiting Ca 2ϩ influx in the relaxation to diamide resulted in a characterization of the properties of the processes that were involved.
Methods

Materials
Many of the reagents used in the present study were obtained from sources previously described. [15] [16] [17] [18] [19] Diamide, dithiothreitol (DTT), 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU), tetraethylammonium chloride (TEA), charybdotoxin (CTX), glibenclamide, 4-aminopyridine, genistein, phorbol 12,13-dibutyrate (PDBu), Bay K8644, EGTA, nifedipine, and diltiazem were from Sigma Chemical Co. LY83583 was from Cayman Chemicals.
Measurement of Changes in Force in BCAs
Isolated endothelium-removed left circumflex coronary arterial rings were prepared from slaughterhouse-derived bovine hearts and studied for changes in isometric force, as previously described. 16 -18 The rings were incubated in individually thermostated (37°C) 10-mL baths (Metro Scientific) for 2 hours at an optimal passive tension of 5 g in Krebs' bicarbonate buffer (pH 7.4) containing the following (in mmol/L): NaCl 118, KCl 4.7, CaCl 2 1.5, NaHCO 3 25, MgSO 4 1.1, KH 2 PO 4 1.2, and glucose 5.6, gassed with 21% O 2 /5% CO 2 (balance N 2 ). After a 2-hour equilibration and a brief depolarization with 123 mmol/L KCl, the BCAs were then allowed to reequilibrate for 30 minutes before the experiments were conducted. After a 30minute equilibration period, the experiments described in Results were conducted. The doses of contractile agents were selected to generate Ϸ70% of maximal force (typically Ϸ14 g of force). In studies examining the actions of mechanistic inhibitors on the response to diamide, probes were usually added together with contractile agents, and they were incubated with BCAs for at least 15 minutes before exposure to increasing cumulative concentrations of diamide or other relaxing agents. BCNU, 1H- [1, 2, 4] oxadiazolo [4,3a] quinoxalin-1-one (ODQ), LY83583, glibenclamide, genistein, and nifedipine were dissolved in dimethyl sulfoxide, and the 0.05% to 0.1% concentrations used did not alter the vascular responses. None of the probes or treatments, except those mentioned in Results, had a statistically significant effect on force generation.
Statistical Analysis
Results are expressed as meanϮSE, with n equal to the number of animals used. Comparisons between groups were made by ANOVA and Student t test with a Bonferroni correction for multiple comparisons. A value of PϽ0.05 was used to determine statistical significance. Figure 1A contains a typical experiment using BCAs initially precontracted with the thromboxane A 2 receptor agonist U46619 (0.1 mol/L) before exposure to the thiol oxidant diamide. As shown in Figure 1A (top), a dose of diamide (0.3 mmol/L) that oxidizes thiols in cardiovascular preparations 20 -22 caused BCAs to relax (74Ϯ8% relaxation, nϭ4) in a manner that was reversed (106Ϯ3% recovery) by the thiol reductant DTT (1 mmol/L). DTT did not reverse the relaxation (90Ϯ4%, nϭ6) elicited by stimulation of adenylate cyclase by 1 mol/L forskolin (Ϫ2Ϯ4% recovery, Figure 1A , middle). Washing out of the diamide with 37°C Krebs' buffer containing U46619 also caused a rapid reversal (107Ϯ2% recovery, nϭ8) of the relaxation (64Ϯ6% relaxation) to diamide (See Figure 1A, bottom ).
Results
Diamide Causes a Reversible Relaxation of BCAs
An Inhibitor of GSH Reductase Enhances BCA Relaxation to Diamide
Inhibition of GSH reductase 23 by a 30-minute pretreatment with 0.1 mmol/L BCNU followed by washout was used to examine whether preventing the reduction of oxidized GSH enhanced the response to the thiol oxidant diamide. The conditions used for the BCNU treatment were optimized in preliminary experiments to minimize its previously reported inhibitory effects on force generation and relaxation to NO. 22 Although BCNU pretreatment did not significantly depress the contraction caused by the subsequent addition of 0.1 mol/L U46619, the dose of U46619 was increased to 0.3 mol/L in BCNU-pretreated vessels, which showed a slow development of force. Under these conditions, as shown in Figure 1B 
Effects of Inhibitors of sGC on BCA Relaxation to Diamide
Pretreatment with inhibitors of the activation of sGC, including 10 mol/L ODQ, methylene blue, and LY83583, was used to examine their potential effects on BCA relaxation to diamide. BCAs were initially precontracted with either 0.1 mol/L U46619 or 30 mmol/L KCl in the absence or presence of the inhibitors of sGC activation, and then the relaxant effects of diamide (10 mol/L to 1 mmol/L) were examined. As shown in Figure 2A , none of these inhibitors altered relaxation to diamide in BCAs precontracted with either U46619 or KCl. The data in Figure 2A also indicate that relaxation responses to each dose of diamide were markedly reduced (P Ͻ0.05) in BCAs precontracted with 30 mmol/L KCl compared with BCAs precontracted with 0.1 mol/L U46619.
Effects of K ؉ Channel Blockers on BCA Relaxation to Diamide
K ϩ channel blockers for channels including the Ca 2ϩdependent K ϩ channels (10 mmol/L TEA and 50 nmol/L CTX), ATP-dependent K ϩ channels (10 mol/L glibenclamide), and voltage-gated K ϩ channels (1 mmol/L 4-aminopyridine) 24 were used to examine their potential effects on BCA relaxation to diamide. BCAs were initially precontracted with 0.1 mol/L U46619 in the absence or presence of the K ϩ channel blockers, and then the relaxant effects of diamide (10 mol/L to 1 mmol/L) were examined. As shown in Figure 2B , pretreatment with these blockers did not alter the BCA relaxation to diamide in U46619-precontracted BCAs. The combined presence of CTX and glibenclamide also did not alter the relaxation to diamide (nϭ4, not shown).
Effects of Probes for O 2 Metabolism on BCA Relaxation to Diamide
To examine whether O 2 tension affects diamide-elicited relaxation, experiments were performed in either normoxic or severely hypoxic conditions. BCAs were initially precontracted with either 0.1 mol/L U46619 or 30 mmol/L KCl in the absence or presence of a severely hypoxic atmosphere (95% N 2 /5% CO 2 , PO 2 8 to 10 mm Hg). Hypoxic conditions did not affect the relaxation to diamide in BCAs precontracted with either U46619 or KCl (see Figure 3A ). The effects of altering BCA levels of superoxide on the response to diamide were examined to determine whether the levels of this species influenced relaxation to this agent. Superoxide levels were increased by inhibition of CuZn superoxide dismutase either by using a 30-minute pretreatment with 10 mmol/L diethyldithiocarbamic acid (DETCA), followed by washout before contraction, 15 or by contracting BCAs with either 0.1 mol/L U46619 or 30 mmol/L KCl in the presence of 1 mmol/L NaCN. 25 Superoxide levels were lowered by contracting BCAs with either 0.1 mol/L U46619 or 30 mmol/L KCl in the presence of an intracellular scavenger of superoxide that promotes H 2 O 2 formation (10 mmol/L 4,5-dihydroxy-1,3-benzenedisulfonic acid [Tiron]). 16 As shown by the data in Figure 3B , these methods of altering BCA levels of superoxide did not alter the relaxation elicited by subsequent exposure of the BCAs to increasing cumulative concentrations of diamide (10 mol/L to 1 mmol/L) in BCAs precontracted with either U46619 or KCl. None of the probes examined had a significant effect on contraction to U46619, whereas N 2 and DETCA decreased (P Ͻ0.05) contraction to KCl by 26% and 35%, respectively.
Effects of Inhibition of Tyrosine Kinases on BCA Relaxation to Diamide
The effects of inhibiting tyrosine kinase activity in BCAs with 10 mol/L genistein on the relaxation to diamide was examined to determine whether any of the thiol redoxsensitive processes that influence signaling through tyrosine phosphorylation participate in this response. BCAs were initially precontracted with either 0.1 mol/L U46619 or 30 mmol/L KCl in the absence or presence of genistein, and then the relaxant effects of diamide (10 mol/L to 1 mmol/L) were examined. This agent did not significantly alter the response to diamide in BCAs precontracted with either U46619 or KCl (panel C of Figure II , which can be accessed online at http://atvb.ahajournals.org).
Effects of Different Types of Contractile Stimuli on BCA Relaxation to Diamide
To examine whether the sensitivity of BCA relaxation to diamide is dependent on the signaling mechanisms involved in the stimuli used for contraction, vessels were precontracted to similar levels of force with either 0.1 mol/L U46619, 1 mol/L Bay K8644 (L-type Ca 2ϩ channel opener), or 10 mol/L PDBu (protein kinase C activator), and then the concentration dependence of the diamide-elicited relaxation was compared. Bay K8644 was applied in the presence of 14.7 mmol/L KCl (a concentration of KCl that did not affect vascular tone), because Bay K8644 requires a subthreshold depolarization to cause contraction. 26 As shown in Figure 4A , diamide-elicited relaxation was almost eliminated when vessels were precontracted with PDBu. Although there was a right shift in the concentration-response curve when vessels were precontracted with Bay K8644 compared with U46619, 1 mmol/L diamide caused almost full relaxation of BCAs precontracted with either agent. To elucidate whether PDBuelicited contraction is modulated by the presence of extracellular Ca 2ϩ , vessels were contracted in Ca 2ϩ -free solution containing 1 mmol/L EGTA, and then the maximal stable contraction was compared with that in normal Krebs' solution. PDBu (10 mol/L) caused substantial contraction even in Ca 2ϩ -free solution, and this contraction was only 29% (nϭ15) less than that in Ca 2ϩ -containing solution, indicating that PDBu-elicited contraction is largely independent of extracellular Ca 2ϩ .
To assess whether other relaxants cause vascular relaxation when vessels are precontracted with PDBu, the NO donor SNAP or the cAMP stimulant forskolin were applied to BCAs precontracted with U46619, Bay K8644, or PDBu. Although each contractile agent showed different sensitivity to vasorelaxant agents, SNAP ( Figure 4B ) and forskolin (see panel C of Figure III , which can be accessed online at http://atvb.ahajournals.org) caused substantial relaxation of PDBu-precontracted BCAs.
Effects of Diamide on Contraction to Different Types of Stimuli Elicited in Ca 2؉ -Free Solution Followed by Addition of CaCl 2
In this series of experiments, vessels were first contracted with 30 mmol/L KCl in normal Krebs' solution, followed by washout, and subsequent contractile responses were expressed as a percentage of the initial response to 30 mmol/L KCl. BCAs were then placed in Ca 2ϩ -free Krebs' solution containing 0.1 mmol/L EGTA, and then the contractile effects of 10 mol/L 5-hydroxytryptamine (5-HT), 30 mmol/L KCl, or 1 mol/L Bay K8644 (14.7 mmol/L KCl) were examined in the absence or presence of 1 mmol/L diamide, followed by addition of 1.5 mmol/L CaCl 2 to detect contractile responses originating from the initial release of intracellular Ca 2ϩ and the subsequent influx of extracellular Ca 2ϩ , respectively. Diamide was added 10 minutes before the application of contractile agents, and the initial response was observed for 5 to 10 minutes before the addition of CaCl 2 . Figure 5A (top) shows a typical BCA response to 10 mol/L 5-HT in Ca 2ϩ -free solution and the subsequent contraction elicited by the addition of 1.5 mmol/L CaCl 2 either in the absence or presence of 1 mmol/L diamide. In the absence of diamide, 5-HT caused rapid transient contraction, followed by sustained tonic contraction on addition of CaCl 2 . In the presence of 1 mmol/L diamide, the initial transient contraction was not significantly affected, but subsequent contraction elicited by CaCl 2 was markedly inhibited. These responses are summarized in Figure 5B . In some separate experiments in which 5-HT was washed out after the initial transient contraction, no apparent contraction was observed after adding CaCl 2 , indicating that capacitative Ca 2ϩ entry 27 had a minimum role, if any, in the contraction elicited by 5-HT under these experimental conditions (nϭ4, not shown). 
5-Hydroxytryptamine
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Potassium Chloride Figure 5A (middle) shows a typical BCA response to 30 mmol/L KCl in Ca 2ϩ -free solution and the subsequent contraction elicited by the addition of 1.5 mmol/L CaCl 2 in the absence or presence of 1 mmol/L diamide. No significant contraction was observed in Ca 2ϩ -free solution in the absence or presence of 1 mmol/L diamide. Subsequent addition of 1.5 mmol/L CaCl 2 caused a sustained contraction in the absence of diamide; however, this sustained contraction was markedly inhibited by the presence of 1 mmol/L diamide. These responses are summarized in Figure 5B . In some separate experiments in which KCl was washed out after 5 minutes, no apparent contraction was observed after adding CaCl 2 , indicating that capacitative Ca 2ϩ entry had a minimum role, if any, in the contraction elicited by KCl under these experimental conditions (nϭ4, not shown). Figure 5A (bottom) shows a typical BCA response to an L-type Ca 2ϩ channel opener, 1 mol/L Bay K8644, in Ca 2ϩ -free solution and the subsequent contraction elicited by the addition of 1.5 mmol/L CaCl 2 in the absence or presence of 1 mmol/L diamide. Similar to the responses to 30 mmol/L KCl, Bay K8644 did not cause any significant contraction in Ca 2ϩ -free solution, and the subsequent addition of 1.5 mmol/L CaCl 2 caused a sustained contraction in the absence of diamide; this sustained contraction was markedly inhibited by the presence of 1 mmol/L diamide. These responses are summarized in Figure 5B .
Bay K8644
Effects of L-Type Ca 2؉ Channel Blockers on BCA Relaxation to Diamide
The effects of L-type Ca 2ϩ channel blockers nifedipine and diltiazem on the response to diamide were examined to determine whether these channels contributed to its relaxant actions. In initial experiments, these agents were observed to cause a similar degree of inhibition of contraction to 0.1 mol/L U46619 or 30 mmol/L KCl at each dose examined. The inhibition of contraction of 53.5Ϯ2.0% by 1 mol/L nifedipine (nϭ4) and 72.0Ϯ4.2% by 10 mol/L diltiazem (nϭ4) could be reversed by increasing the concentration of U46619 from 0.1 to 0.3 to 1.0 mol/L. In contrast, it was difficult to obtain similar levels of force in the absence or presence of nifedipine or diltiazem through increasing the concentration of KCl. As shown in Figure 6A 
Discussion
In the present study, the thiol oxidant diamide was observed to cause a reversible concentration-dependent relaxation of endothelium-removed BCAs, which appeared to be mediated through alterations in a thiol redox process, inasmuch as the response was enhanced by an inhibitor of GSH reductase, and it was reversed by the thiol reductant DTT or by removal of the diamide. Previous studies on a variety of cardiovascular tissue and cellular preparations (eg, see References 20 to 22) have demonstrated that the concentrations of diamide observed to cause coronary arterial relaxation in the present study consistently cause severe degrees of reversible GSH oxidation and S-thiolation of proteins. The actions of probes used in the present study suggest that the relaxing mechanism activated by diamide does not seem to involve the stimulation of sGC or tyrosine kinases, the opening of K ϩ channels, or a process involving O 2 metabolism or the modulation of reactive O 2 species. Under the conditions of the present study, diamide appears to function primarily through inhibiting a mechanism of Ca 2ϩ influx, and evidence of its promotion of relaxation through influencing the signaling mechanisms associated with the 5-HT receptor-mediated release of Ca 2ϩ from intracellular organelles or contractile mechanisms regulated through the stimulation of protein kinase C could not be detected. Thiol redox has multiple ways of potentially interacting with systems that regulate the activity of sGC. Because the metabolism of H 2 O 2 by GSH peroxidase appears to function as a modulator of the stimulation of sGC by peroxide metabolism by catalase in BCAs, 17 diamide could cause relaxation by increasing the intracellular levels of H 2 O 2 and its metabolism by catalase. However, this mechanism does not appear to mediate the relaxation to diamide, inasmuch as it has been shown in the present study that inhibitors of sGC stimulation do not alter relaxation to this agent. In a previous study, it has also been observed that the inactivation of catalase does not alter the relaxation of endothelium-removed bovine coronary arteries to diamide. 17 In addition, the catalytic activity of sGC appears to be inactivated by disulfide formation or S-thiolation through reactions with disulfides, including the oxidized form of GSH, 6 and this process may function as an endogenous mechanism of inhibiting the vascular form of sGC. 7 Thus, the stimulation of sGC does not appear to be involved in the relaxation to diamide.
There is substantial evidence that many of the different forms of K ϩ channels are potentially regulated by thiol redox processes. 4, 28 In the present study, it was observed that agents that inhibit most of the known forms of K ϩ channels did not alter the response to diamide. Because hypoxia did not alter relaxation to diamide, it appears that processes associated with the PO 2 -dependent regulation of K ϩ channels 4,5 did not contribute to preventing the detection of a role for K ϩ channels in the actions of this thiol oxidant. Thus, a relaxing mechanism activated by hyperpolarization as a result of the opening of plasma membrane K ϩ channels does not seem to participate in the mechanism of relaxation to diamide.
The absence of effects of other probes used in the present study that altered O 2 metabolism on relaxation to diamide were consistent with the absence of a role for several additional mechanisms. Because modulating superoxide levels, NaCN, and severe hypoxia did not alter the response to diamide, it appears that relaxation to this agent does not involve alterations in a signaling mechanism dependent on the formation of reactive O 2 species (eg, H 2 O 2 ) or other processes controlled by PO 2 , such as energy metabolism. Because superoxide-derived oxidants and thiol redox signaling appear to activate multiple genistein-inhibitable tyrosine kinase-dependent signaling mechanisms, including processes dependent on activation of p21 ras , mitogen-activated protein kinases, and phospholipases, 9 -11 these processes may also not be involved in relaxation to diamide.
Various approaches were investigated to probe the role of systems that control the levels of intracellular Ca 2ϩ in BCAs because systems such as sarcoplasmic reticulum Ca 2ϩ uptake is thought to be regulated by oxidant mechanisms through changes in thiol redox. 13, 14 The absence of a relaxation to diamide in BCAs contracted with PDBu, an activator of protein kinase C, suggested that a key aspect of the mechanism of action of diamide could involve either a process that is inhibited by protein kinase C or a system that controls the levels of intracellular Ca 2ϩ . This latter hypothesis is based on the observation that contraction to PDBu is largely independent of the presence of extracellular Ca 2ϩ under the conditions examined in the present study. It is important to note that PDBu does not prevent BCA relaxation in a nonspecific manner, because SNAP and forskolin caused substantial relaxation in BCAs contracted with PDBu. Because the initial contraction to 5-HT in the absence of extracellular Ca 2ϩ was not altered by diamide, this thiol oxidant does not appear to be influencing the processes involved in the release of sarcoplasmic reticulum Ca 2ϩ by the 5-HT receptor-regulated mechanism. The absence of an inhibition of force generation by the protein kinase C activator PDBu or the initial contrac- tion to 5-HT in the absence of Ca 2ϩ is also consistent with diamide not directly altering the function of contractile proteins involved in the generation of force under the conditions of these experiments. However, further increases in thiol oxidation could influence these thiol-dependent signaling systems. Observation of a marked inhibition of contraction caused by the readdition of Ca 2ϩ in the presence of 5-HT or agents that activate voltage-dependent Ca 2ϩ channels implicates a role for inhibition of sarcolemmal Ca 2ϩ influx in the mechanism of relaxation to diamide.
The L-type Ca 2ϩ channel is one of the best identified Ca 2ϩ channels in smooth muscle, and this channel may be the primary channel that mediates Ca 2ϩ influx associated with receptor and voltage-dependent contraction in smooth muscle. 27 Because L-type Ca 2ϩ channel blockers selectively attenuated the response to diamide, these channels appear to contribute to its mechanism of relaxation. The observation that L-type Ca 2ϩ channel blockers had a similar potency in relaxing BCAs contracted with KCl and U46619, compared with the markedly reduced potency of diamide on arteries contracted with KCl, suggests that diamide may also be simultaneously activating an additional mechanism that could potentially function through enhancing the contractile actions of KCl. Interestingly, studies on the cloned smooth muscle L-type Ca 2ϩ channel have identified a key role for a thiol redox process in controlling its activity, in which oxidation closes the channel. 29 Although diamide could be functioning in a manner similar to that of L-type Ca 2ϩ channel blockers, the observation that relaxation to diamide is enhanced in the presence of inhibition of GSH reductase is consistent with a mechanism controlled by intracellular thiol redox. Thus, diamide appears to function through activating a thiol oxidation mechanism that inhibits L-type Ca 2ϩ channels.
The present study has identified a potentially novel vasodilator mechanism in BCAs that appears to be mediated through closure of a plasma membrane channel that seems to be the L-type Ca 2ϩ channel by a thiol oxidation mechanism. Because removal of the diamide caused a rapid reversal of this relaxation, enzymes that normally control cellular thiol redox processes, including GSH and thioredoxin reductases, 12 are likely to participate in reversal of the alterations caused by diamide. Although it is possible that some of the other thiol redox-related signaling mechanisms examined in the present study are altered by diamide, it appears that closure of a plasma membrane Ca 2ϩ channel is the dominant relaxing mechanism activated in BCAs under the conditions examined. The coronary vasodilator mechanism investigated in the present study may be of importance in situations associated with thiol oxidation caused by oxidant and/or nitrosative stress, such as cardiac ischemia/reperfusion and inflammation.
